TY  - JOUR
AU  - Hellner, Karin
AU  - Miranda, Fabrizio
AU  - Fotso Chedom, Donatien
AU  - Herrero-Gonzalez, Sandra
AU  - Hayden, Daniel M
AU  - Tearle, Rick
AU  - Artibani, Mara
AU  - KaramiNejadRanjbar, Mohammad
AU  - Williams, Ruth
AU  - Gaitskell, Kezia
AU  - Elorbany, Samar
AU  - Xu, Ruoyan
AU  - Laios, Alex
AU  - Buiga, Petronela
AU  - Ahmed, Karim
AU  - Dhar, Sunanda
AU  - Zhang, Rebecca Yu
AU  - Campo, Leticia
AU  - Myers, Kevin A
AU  - Lozano, María
AU  - Ruiz-Miró, María
AU  - Gatius, Sónia
AU  - Mota, Alba
AU  - Moreno-Bueno, Gema
AU  - Matias-Guiu, Xavier
AU  - Benitez, Javier
AU  - Witty, Lorna
AU  - McVean, Gil
AU  - Leedham, Simon
AU  - Tomlinson, Ian
AU  - Drmanac, Radoje
AU  - Cazier, Jean-Baptiste
AU  - Klein, Robert
AU  - Dunne, Kevin
AU  - Bast, Robert C
AU  - Kennedy, Stephen H
AU  - Hassan, Bassim
AU  - Lise, Stefano
AU  - Garcia, María José
AU  - Peters, Brock A
AU  - Yau, Christopher
AU  - Sauka-Spengler, Tatjana
AU  - Ahmed, Ahmed Ashour
PY  - 2016
DO  - 10.1016/j.ebiom.2016.06.048
SN  - 23523964
UR  - http://hdl.handle.net/20.500.12105/8535
AB  - Current screening methods for ovarian cancer can only detect advanced disease. Earlier detection has proved difficult because the molecular precursors involved in the natural history of the disease are unknown. To identify early driver mutations in...
LA  - eng
PB  - Elsevier
KW  - BRCA mutations
KW  - Fallopian tube
KW  - Ovarian cancer
KW  - Precancer
KW  - SOX2
KW  - Screening
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - Biomarkers, Tumor
KW  - Cell Differentiation
KW  - Cell Line, Tumor
KW  - Drug Resistance, Neoplasm
KW  - Fallopian Tubes
KW  - Female
KW  - Genes, BRCA1
KW  - Genes, BRCA2
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Image-Guided Biopsy
KW  - Laparoscopy
KW  - Middle Aged
KW  - Models, Biological
KW  - Mutation
KW  - Neoplasm Staging
KW  - Neoplastic Stem Cells
KW  - Ovarian Neoplasms
KW  - Regulatory Sequences, Nucleic Acid
KW  - SOXB1 Transcription Factors
KW  - Gene Expression
KW  - Precancerous Conditions
TI  - Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
TY  - journal article
ER  -